Tumor vaccine is the use of tumor antigen to cause the body to create particular anti-tumor effect, activate the body’s own immune defense mechanism, and achieve the function of tumor therapy orRead More…
Untreated rabies infection is almost 100 percent fatal, killing between 50000 and 60000 people a year, many of whom are children. Rabies vaccine for human use consists of inactivated virus, which hasRead More…
Adenovirus (Ad) vector vaccines have been frequently reported in recent years as the main force against COVID-19. In fact, Ad vaccines have a wide range of applications, and also play an importantRead More…
Vaccines have traditionally been used to prevent infectious diseases. However, the ability of this drug to induce and amplify antigen-specific immune responses has long been considered a potentially valuable tool for cancerRead More…
Recently, the research team of Doha Cornell Medical Center published the research results entitled “Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar” on the medRxiv. The study foundRead More…
Under the background of the global COVID-19 pandemic, amazing progress has been made in the field of vaccine research and development, and there are more and more different types of vaccines basedRead More…
Using nucleoside modified mRNAs in lipid nanoparticles (mRNA-LNP) as a vaccine for COVID-19 may successfully predict a new era of vaccine development. For HIV-1, polyvalent enveloped trimer protein nanoparticles may be usedRead More…
Recently, the US Food and Drug Administration (FDA) has granted respiratory syncytial virus (RSV) bivalent pre-fused F subunit vaccine (RSVpreF) breakthrough therapy recognition (BTD), which is an active immunization for the pregnantRead More…
Nearly 40 years after the discovery of HIV, it has killed 36.3 million people, but so far there is still no effective vaccine available. In a new study, however, researchers from theRead More…
Viruses such as HIV or hepatitis C virus (HCV) can destroy the immune system. So far, one way to develop vaccines against these chronic infections is to target memory B cells, aRead More…